BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21464784)

  • 21. [Primary cutaneous anaplastic large cell lymphoma: Report of one case].
    Navarrete-Dechent C; Molgó M; Sandoval-Osses M; González S
    Rev Med Chil; 2015 Oct; 143(10):1351-5. PubMed ID: 26633281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Cutaneous CD30+ Lymphoproliferative Disorders in a Patient with Severe Atopic Dermatitis: Is There a Causative Link?
    Zychowska M; Woźniak Z; Maj J
    Acta Derm Venereol; 2018 Jan; 98(1):123-125. PubMed ID: 28952656
    [No Abstract]   [Full Text] [Related]  

  • 23. CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right.
    Kadin ME
    Br J Dermatol; 2015 Jun; 172(6):1478-1479. PubMed ID: 26036155
    [No Abstract]   [Full Text] [Related]  

  • 24. The importance of accurately characterizing lymphoproliferative disease.
    Foss FM
    Oncology (Williston Park); 2009 Nov; 23(13):1168, 1170. PubMed ID: 20043467
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
    Masuda Y; Imura K; Sano Y; Yagi H
    J Dermatol; 2024 Feb; 51(2):e53-e54. PubMed ID: 37752863
    [No Abstract]   [Full Text] [Related]  

  • 26. Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma.
    Shalabi D; Ringe J; Lee JB; Nikbakht N
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
    McNab PM; Jukic DM; Mills O; Browarsky I
    Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
    Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
    Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Laly P; Ingen-Housz-Oro S; Beylot-Barry M; Verneuil L; Adamski H; Brice P; Bagot M
    JAMA Dermatol; 2015 Sep; 151(9):1030-1. PubMed ID: 26108120
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
    Papalas JA; Van Mater D; Wang E
    Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous anaplastic large cell lymphoma of the medial canthus and orbit.
    Koreen IV; Cho RI; Frueh BR; Elner VM
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):63-5. PubMed ID: 19273934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
    Shah M; Pawar M; Zawar V
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):33-34. PubMed ID: 29589643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous extranodal marginal zone B-cell lymphoma of the eyelid skin: Diagnostic clues and distinction from other ocular adnexal diseases.
    Stagner AM; Jakobiec FA; Freitag SK
    Surv Ophthalmol; 2016; 61(3):333-8. PubMed ID: 26545575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease.
    Mahajan VK; Jindal R
    Indian J Dermatol Venereol Leprol; 2016; 82(1):98-101. PubMed ID: 26728828
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant?
    Kumaran MS; Jithendriya M; Nagaraj P; Tirumalae R; Jayaseelan E
    Indian J Dermatol Venereol Leprol; 2012; 78(3):354-7. PubMed ID: 22565437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
    Ferrara G; Ena L; Cota C; Cerroni L
    Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.